Walgreens plans to start selling creams, patches and sprays containing CBD - a cannabis compound that doesn't get people high - at stores in IL and eight other states, the Deerfield-based retail pharmacy giant said Tuesday.
Cannabidiol, commonly known as CBD, comes from the hemp plant, a cousin of the marijuana plant, according to NBC News.
Walgreens will soon start selling cannabis-based products. Market research firm Brightfield Group projects that CBD product sales will reach $22 billion by 2022. The FDA warns companies that introducing food containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, dietary supplements, regardless of whether the substances are hemp-derived, is against the law, according to Forbes. The U.S. Food and Drug Administration has already warned the makers and sellers of CBD products to steer clear of making overt health claims.
CBD products produced from marijuana will not be regulated as marijuana if the THC content is below 0.3%.
Harry Kane: I want to play in the NFL
Sheringham admitted that the late-season switch to a new home might be "a distraction" for his former side. Fans were finally allowed through the turnstiles to see Spurs' under 18s beat Southampton under 18s 3-1.
Stolen Picasso unearthed by ‘Indiana Jones of art’
Mr Brand said he had to act swiftly, otherwise, the painting may have disappeared back into the underworld. Earlier this month, he got a response.
Arizona's ISM Raceway to host NASCAR Championship Weekend in November 2020
That includes consecutive weekends off for the first time in the modern era so that NBC Sports can focus on the Tokyo Olympics. An official announcement about the move is expected Tuesday afternoon, when NASCAR unveils its revamped racing schedule.
The market for CBD products with almost non-detectable levels of THC has exploded in recent years and is expected to exceed $22 billion by 2022.
"The floodgates are opening right now for CBD products, with more and more chained retailers beginning to stock the products".
"We have partnered with CBD product manufacturers that are complying with applicable laws and that meet CVS's high standards for quality", a spokesman said in an email to MarketWatch. "Topicals are viewed as a lower risk level than ingestible products, and is expected to quickly overtake tinctures as the dominant CBD product type".